Abbvie Inc. vs Becton, Dickinson and Co.
ABBV vs BDX — side-by-side comparison from reported financials. ABBV leads 8, BDX leads 4 of 12 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
Becton, Dickinson and Co.
BDX · Healthcare
$183.75+0.55%Strained
| Metric | ABBV | BDX |
|---|---|---|
| Price | $276.43 | $183.75 |
| Market cap | $488B | $50.0B |
| Revenue (TTM) | $64.4B | $20.1B |
| Revenue growth | +1.8% | +5.0% |
| Net margin | 9.8% | 4.7% |
| Free cash flow | $18.2B | $2.73B |
| Net cash (debt) | ($56.2B) | ($18.5B) |
| 1-year price return | +19.8% | -2.8% |
| P/E | 77.4 | 53.1 |
| P/E vs own history (cheap-side %) | 23% | 31% |
| Dividend yield | 2.45% | 2.34% |
| Return on equity | 96% | 4% |
| Altman Z-score | 2.33 | 1.95 |
| CV checks passed | 9 of 11 | 7 of 11 |
| Employees | 57,000 | 72,000 |
Full résumé-style profiles: ABBV CV · BDX CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.